SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-17-002596
Filing Date
2017-08-31
Accepted
2017-08-31 16:34:36
Documents
15
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 20-F zk1720503.htm 20-F 2924521
2 EXHIBIT 4.21 exhibit_4-21.htm EX-4.21 179303
3 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 2320
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10317
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10151
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4728
7 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4850
8 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 2731
9 image0.jpg GRAPHIC 3488
10 img101_v1.jpg GRAPHIC 33789
11 img102_v1.jpg GRAPHIC 5693
12 img103_v1.jpg GRAPHIC 4390
13 img104_v1.jpg GRAPHIC 2345
14 img105_v1.jpg GRAPHIC 4707
15 img106_v1.jpg GRAPHIC 3619
  Complete submission text file 0001178913-17-002596.txt   3220598
Mailing Address P.O. BOX 655 CARLTON, SOUTH VIC C3 3053
Business Address P.O. BOX 655 CARLTON, SOUTH VIC C3 3053 61-0-9824-5254
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 171063709
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1